Phase II study of cetuximab plus concomitant boost radiotherapy in Japanese patients with locally advanced squamous cell carcinoma of the head and neck
about
Asian expert recommendation on management of skin and mucosal effects of radiation, with or without the addition of cetuximab or chemotherapy, in treatment of head and neck squamous cell carcinoma.Initial experience of radiotherapy plus cetuximab for Japanese head and neck cancer patients.Update of cetuximab for non-melanoma skin cancer.Recent multidisciplinary approach with molecular targeted drugs for advanced head and neck cancer.Retrospective evaluation of concomitant cetuximab and radiotherapy tolerance for locoregional advanced head and neck squamous cell carcinoma treatment in patients unfit for platinum-based chemotherapy.3q26-29 Amplification in head and neck squamous cell carcinoma: a review of established and prospective oncogenes.Artificial nutrition dependence after cetuximab versus cisplatin combined with radiotherapy for advanced head and neck cancer: A propensity score-matched analysis.Impact of prophylactic percutaneous endoscopic gastrostomy tube placement on treatment tolerance in head and neck cancer patients treated with cetuximab plus radiation.Retrospective analysis of premedication, glucocorticosteroids, and H1-antihistamines for preventing infusion reactions associated with cetuximab treatment of patients with head and neck cancerLoss of EGF-dependent cell proliferation ability on radioresistant cell HepG2-8960-R.Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma.Mild pulmonary emphysema a risk factor for interstitial lung disease when using cetuximab for squamous cell carcinoma of the head and neckComparison of acute toxicities associated with cetuximab-based bioradiotherapy and platinum-based chemoradiotherapy for head and neck squamous cell carcinomas: A single-institution retrospective study in JapanPostoperative Bio-Chemoradiotherapy Using Cetuximab and Docetaxel in Patients With Cis-Platinum-Intolerant Core High-Risk Head and Neck Cancer: Protocol of a Phase 2 Nonrandomized Clinical Trial
P2860
Q35905979-527C2BE6-8990-44EE-979B-9A84B031EBF7Q36078657-DE9E1F78-8130-4D8D-AA38-E3A9AFE0359EQ38175499-608A337C-9363-4B11-8865-10E3BE9E3103Q38191864-38C2506A-D63A-4C42-AEAC-A6F6FD35E3A8Q38851239-0639222E-95F1-4C8F-80EE-2522C2B2C172Q39186868-9C627E04-3A9D-4595-8F13-32A92702E674Q40578506-139B98BD-C7E9-4E73-87E0-A86EC8315C2AQ40693968-E1F9B1EC-1508-440F-805F-40757BCD0633Q42245331-B567E518-0D97-4732-9ED9-B84AB5272EB4Q53622278-1B0741EA-B4CC-480B-AACE-872CAE7C746EQ55249763-FA3F5C2D-F190-43C3-8A3C-3710DD16DC71Q58171843-07F3E084-25FD-4487-9834-D259C995367EQ58269419-148E4174-9DE2-4439-9A52-BE370BA0601EQ58711457-AA887565-582B-4E6F-B85A-CFDEE5F8BDE9
P2860
Phase II study of cetuximab plus concomitant boost radiotherapy in Japanese patients with locally advanced squamous cell carcinoma of the head and neck
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Phase II study of cetuximab pl ...... carcinoma of the head and neck
@ast
Phase II study of cetuximab pl ...... carcinoma of the head and neck
@en
type
label
Phase II study of cetuximab pl ...... carcinoma of the head and neck
@ast
Phase II study of cetuximab pl ...... carcinoma of the head and neck
@en
prefLabel
Phase II study of cetuximab pl ...... carcinoma of the head and neck
@ast
Phase II study of cetuximab pl ...... carcinoma of the head and neck
@en
P2093
P2860
P356
P1476
Phase II study of cetuximab pl ...... carcinoma of the head and neck
@en
P2093
Barbara de Blas
Frank Beier
Hirofumi Fujii
Makoto Tahara
Masahiko Oguchi
Masato Fujii
Sadamoto Zenda
Satoshi Ishikura
Susumu Okano
Takayuki Yoshino
P2860
P304
P356
10.1093/JJCO/HYT030
P577
2013-03-10T00:00:00Z